| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 10/04/2001 | DE10019067C1 Transdermal plaster comprising dofetilide, is useful for treatment of cardiovascular disorders |
| 10/04/2001 | DE10016356A1 Retard composition for gastrointestinal release of active substance comprises carrier and active substance layers with interposed gastro-insoluble layer |
| 10/04/2001 | DE10014588A1 Sustained-release oral dosage form that floats in gastric fluid includes a blend of polyvinyl acetate and polyvinylpyrrolidone |
| 10/04/2001 | DE10012908A1 Stabilisierte übersättigte transdermale therapeutische Matrixsysteme Stabilized supersaturated matrix transdermal therapeutic systems |
| 10/04/2001 | DE10003767A1 Hautfreundliches Wirkstoffpflaster zur transdermalen Verabreichung nichtsteroidaler Antirheumatika Skin-friendly drug patch for transdermal administration of non-steroidal anti-inflammatory drugs |
| 10/04/2001 | CA2404913A1 Sterol ester compositions |
| 10/04/2001 | CA2404374A1 Use of metal salts to stabilize taxane-based compositions |
| 10/04/2001 | CA2404370A1 Taxane-based compositions and methods of use |
| 10/04/2001 | CA2404147A1 Emulsion containing a plant extract, method for producing said emulsion and for obtaining a plant extract |
| 10/04/2001 | CA2403757A1 Granulated particles with masked taste |
| 10/04/2001 | CA2402613A1 Cationic liposomes |
| 10/04/2001 | CA2402187A1 Intracorporeal medicaments comprising halogenated xanthene for photodynamic treatment of disease |
| 10/04/2001 | CA2382089A1 Biomedical assay device |
| 10/03/2001 | CN1315949A Salts of paroxetine |
| 10/03/2001 | CN1315936A Compounds and compositions for delivering active agents |
| 10/03/2001 | CN1315865A Stabilized pharmaceutical Composition in lyophilized form |
| 10/03/2001 | CN1315864A Powdery preparation for mucosal administration containing polymeric medicine |
| 10/03/2001 | CN1315862A Medicinal compositions for treating eye diseases |
| 10/03/2001 | CN1315855A Immediate release tablet |
| 10/03/2001 | CN1315854A Microparticles |
| 10/03/2001 | CN1315853A Bioenhanced formulations comprising eprosartan in oral dosage form |
| 10/03/2001 | CN1315852A Medicinal aerosol formulations |
| 10/03/2001 | CN1315851A Oral care compositions |
| 10/03/2001 | CN1315835A Antioxidant composition comprising acetyl L-carnitine and alpha-lipoic acid |
| 10/03/2001 | CN1315206A Interferon suppository and its preparing process |
| 10/03/2001 | CN1315204A Exterior-applied medicine for giving up smoking |
| 10/03/2001 | CN1315195A Jingan shierkang capsule and its preparing process |
| 10/03/2001 | CN1315193A Ointment for treating acne and its preparing process |
| 10/03/2001 | CN1315192A Ointment for treating psoriasis and its preparing process |
| 10/03/2001 | CN1315177A Method for curing sexual dysfunction by specific blood plasma concentration apomorphine |
| 10/03/2001 | CN1315175A Process for preparing ginkgolide injection |
| 10/03/2001 | CN1072021C Composite blood compatible polymer/liquid crystal film and its preparing process |
| 10/03/2001 | CN1072017C Nutritive health food and preparing process thereof |
| 10/02/2001 | US6297421 Stretchable, moisture permeable, non-irritating to skin |
| 10/02/2001 | US6297350 Using cyclic esters as monomers and a metallic salt as catalyst, reproducible preparation of copolyesters with a random sequence under controlled conditions, metal salt of an aminocarboxylic acid, hydroxycarboxylic acid or a |
| 10/02/2001 | US6297289 Dispenser for introducing microscopic particles of propanethial-s-oxide into the eye |
| 10/02/2001 | US6297278 Low cytotoxicity synergistic mixture of a betaine, an amine oxide and an acid in an amount to provide the composition with a ph of 4-8 |
| 10/02/2001 | US6297273 Use of cocoa solids having high cocoa polyphenol content in tabletting compositions and capsule filling compositions |
| 10/02/2001 | US6297240 Particularly diseases caused by elevated intro-ocular pressure, such as ocular hypertension and glaucoma |
| 10/02/2001 | US6297219 Site-specific instillation of cells or site-specific transformation of cells and kits therefor |
| 10/02/2001 | US6297218 Phospholipid complexes prepared from extracts of Vitis vinifera as anti-atherosclerotic agents |
| 10/02/2001 | US6297213 Osteogenic devices |
| 10/02/2001 | US6296882 Non-toxic mucosal disinfectant containing isopropyl alcohol, sesame oil, and lemon oil |
| 10/02/2001 | US6296877 Stable, aqueous dispersions and stable, water-dispersible dry xanthophyll powder, their production and use |
| 10/02/2001 | US6296876 Resistance to dissolution in acid media and dissolves rapidly in neutral to alkaline media; storage stability |
| 10/02/2001 | US6296875 Method for producing a granule |
| 10/02/2001 | US6296874 For therapy of diabetes |
| 10/02/2001 | US6296873 Zero-order sustained release delivery system for carbamazephine derivatives |
| 10/02/2001 | US6296872 Tablet composition of N-(trans-4-isopropylcyclohexanecarbonyl)-D-phenylalanine |
| 10/02/2001 | US6296870 Liposomes containing active agents |
| 10/02/2001 | US6296869 Adhesive cosmetic patch containing alpha or beta hydroxy acids |
| 10/02/2001 | US6296868 Sweetener |
| 10/02/2001 | US6296867 Provides relief to the eye and promotes healing; lens can be shaped to have refractive properties while lens is either positioned on eye or before the lens is positioned on the eye |
| 10/02/2001 | US6296847 Composition for treating benign prostatic hypertrophy |
| 10/02/2001 | US6296844 Administering asialointerferon-.beta.. to mammal for therapy of viral hepatitis |
| 10/02/2001 | US6296842 Forming mixture comprising biologically active agent, a biocompatible polymer, and polymer solvent; removing polymer solvent thereby forming solid polymer/active agent matrix; annealing exterior surface of matrix |
| 10/02/2001 | US6296831 Biodegradation; in cancer tumor therapy |
| 10/02/2001 | CA2159626C Method for delivering beneficial compositions to hair follicles |
| 10/02/2001 | CA2084680C Process for the manufacture of porous cellulose matrices |
| 10/02/2001 | CA2084668C Gelatin coated medicament and process for making same |
| 10/02/2001 | CA2078666C Heterovesicular liposomes |
| 09/30/2001 | CA2310365A1 Passive and active protection against mycobacterial infections |
| 09/27/2001 | WO2001070863A1 Azeotrope-like compositions of pentafluoropropane and water |
| 09/27/2001 | WO2001070694A1 Amorphous torasemide modification |
| 09/27/2001 | WO2001070663A2 Novel amphipathic aldehydes and their use as adjuvants and immunoeffectors |
| 09/27/2001 | WO2001070591A1 Infusion packet with useful and decorative elements, support member, delivery system and method |
| 09/27/2001 | WO2001070577A1 Methods of producing a terminally sterilized topical patch preparation |
| 09/27/2001 | WO2001070291A2 Injectable microspheres for dermal augmentation and tissue bulking |
| 09/27/2001 | WO2001070288A2 Thermoreversible polymers for delivery and retention of osteoinductive proteins |
| 09/27/2001 | WO2001070271A2 Acid-stable base compositions for preparing surfactant free topical compositions |
| 09/27/2001 | WO2001070270A2 Base compositions for preparing surfactant free topical compositions |
| 09/27/2001 | WO2001070253A1 Use of mia in immunotherapy |
| 09/27/2001 | WO2001070249A1 Cosmetic use of hop and ornithine |
| 09/27/2001 | WO2001070242A2 Compositions containing molecular iodine |
| 09/27/2001 | WO2001070238A1 Creatine containing caramel |
| 09/27/2001 | WO2001070234A1 Anaesthetic composition |
| 09/27/2001 | WO2001070225A2 Oxazolidinone tablet formulation |
| 09/27/2001 | WO2001070224A2 Rilmenidine dressing and method for preparing same |
| 09/27/2001 | WO2001070220A1 A method of administering liposomal encapsulated taxane |
| 09/27/2001 | WO2001070206A2 Combination of lecithin with ascorbic acid |
| 09/27/2001 | WO2001070202A1 Plaster containing an active agent |
| 09/27/2001 | WO2001070201A1 Enteric granular preparations of hardly water soluble drugs characterized by containing water-repellent component |
| 09/27/2001 | WO2001070200A1 Pharmaceutical composition for administration to mucosal surfaces |
| 09/27/2001 | WO2001070199A1 Matrices containing nitric oxide donors and reducing agents and their use |
| 09/27/2001 | WO2001070198A1 Stabilized dry powder formulations |
| 09/27/2001 | WO2001070196A2 Sustained release delivery systems for solutes |
| 09/27/2001 | WO2001070195A2 A method and apparatus for coating centers |
| 09/27/2001 | WO2001070194A1 Fast dissolving orally consumable films containing an ion exchange resin as a taste masking agent |
| 09/27/2001 | WO2001070172A2 Solid, water-dispersible, oral pharmaceutical form comprising rifampicin, isoniazid and pyridoxine hydrochloride, method for obtaining and presenting said pharmaceutical form |
| 09/27/2001 | WO2001070170A1 Container for linezolid intravenous solution |
| 09/27/2001 | WO2001070154A1 Device and method for treating urinary incontinence in females |
| 09/27/2001 | WO2001070032A1 Recombinant parainfluenza virus expression systems and vaccines |
| 09/27/2001 | WO2001053320A3 Crystalline composites comprising phytosterols and phytostanols or derivatives thereof |
| 09/27/2001 | WO2001025390A3 Water unstable foam compositions |
| 09/27/2001 | WO2001021207A3 Use of combination of polyoxyethylene sorbitan ester and octoxynol as adjuvant and its use in vaccines |
| 09/27/2001 | WO2001019901A3 Process for making aqueous coated beadlets |
| 09/27/2001 | WO2001019320A3 Phospholipid prodrugs of anti-proliferative drugs |
| 09/27/2001 | WO2001013895A3 Controlled-release sedative-hypnotic compositions and methods related thereto |
| 09/27/2001 | WO2001003650A3 Preservatives for perishable preparations, in particular for cosmetic and pharmaceutical preparations |
| 09/27/2001 | WO2000059489A8 Methods and compositions for the treatment of psychotic and related disorders using ziprasidone metabolites |